title: [Using cycloferon in the complex treatment of herpetic infection in patients with atopic dermatitis].
abstract: Clinical efficacy of including cycloferon liniment in combined treatment of herpetic infection in a group of 40 patients with atopic dermatitis has been analyzed. It is concluded that the administration of cycloferon favors dynamic disappearance of general infectious syndrome, reduces timeline of rash as well as length of local inflammation, accelerates epithelization of erosions (on the average 1.2 - 1.4 times, p < 0.05), decreases frequency of recurrent infections, and reduces the level of pro-inflammatory cytokines in the blood of patients.
authors.forename: T S
authors.initials: TS
authors.lastname: Barkhatova
authors.forename: A A
authors.initials: AA
authors.lastname: Shul'diakov
authors.forename: I B
authors.initials: IB
authors.lastname: Gavrilova
authors.forename: D A
authors.initials: DA
authors.lastname: Sretenskaia
mesh_terms: D000166:Acridines / Q000627:therapeutic use*; D000328:Adult; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006560:Herpes Labialis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D053583:Interleukin-1beta / Q000097:blood / Q000276:immunology; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000097:blood / Q000276:immunology
chemical_list: D000166:Acridines; D005938:Glucocorticoids; D007369:Interferon Inducers; D053583:Interleukin-1beta; D014409:Tumor Necrosis Factor-alpha; C026430:10-carboxymethyl-9-acridanone